GERAGHTY JAMES A

Director at rEVO Biologics, Inc. · on record since Nov 16, 2006
Senior Vice President at GENZYME CORP · on record since May 27, 2008
Director at Aceragen, Inc. · on record since Aug 20, 2013
Director at Voyager Therapeutics, Inc. · on record since Jun 11, 2026
Director at JUNIPER PHARMACEUTICALS INC · on record since Jun 2, 2015
Director at PALVELLA THERAPEUTICS, INC. · on record since May 24, 2017
Director at Fulcrum Therapeutics, Inc. · on record since Jul 18, 2019
Director at Orchard Therapeutics plc · on record since Jan 2, 2020

Insider trading activity of GERAGHTY JAMES A

Transactions on record: 143; since Mar 19, 2004

Open-market buys: 31; $1.6M

Open-market sells: 3; $2.1M

Companies traded: 8; last filing Jul 2, 2026

Figures computed from official regulatory filings — .

Companies where GERAGHTY JAMES A has traded

Fulcrum Therapeutics, Inc.9 tx · $91.6K · Jul 2, 2026
Voyager Therapeutics, Inc.13 tx · $113.1K · Jun 11, 2026
PALVELLA THERAPEUTICS, INC.13 tx · $105.7K · Dec 12, 2024
Orchard Therapeutics plc7 tx · Jan 24, 2024
Aceragen, Inc.28 tx · $1.1M · Jun 27, 2022
JUNIPER PHARMACEUTICALS INC17 tx · $1.4M · Aug 15, 2018
GENZYME CORP28 tx · $16.7M · Apr 6, 2011
28 tx · $65.6K · Jan 5, 2010

Track record of GERAGHTY JAMES A

Statistical track record

Free

Open-market buys: 31

Last buy: Aug 7, 2024

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of GERAGHTY JAMES A

Co-insiders of GERAGHTY JAMES A

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Fulcrum Therapeutics, Inc.Listing on record	Jul 2, 2026	AwardD (derivative)	32,000	0.00 USD	—	SEC
Voyager Therapeutics, Inc.Listing on record	Jun 11, 2026	AwardD (derivative)	30,000	0.00 USD	—	SEC
Fulcrum Therapeutics, Inc.Listing on record	Jun 30, 2025	AwardD (derivative)	36,000	0.00 USD	—	SEC
Voyager Therapeutics, Inc.Listing on record	Jun 4, 2025	AwardD (derivative)	24,000	0.00 USD	—	SEC
PALVELLA THERAPEUTICS, INC.Listing unverified	Dec 12, 2024	Other	-1	0.01 USD	$0	SEC
PALVELLA THERAPEUTICS, INC.Listing unverified	Oct 28, 2024	Buy	1	1.00 USD	$1	SEC
Fulcrum Therapeutics, Inc.Listing on record	Jun 18, 2024	AwardD (derivative)	30,000	0.00 USD	—	SEC
Voyager Therapeutics, Inc.Listing on record	Jun 7, 2024	AwardD (derivative)	24,000	0.00 USD	—	SEC
Orchard Therapeutics plcListing unverified	Jan 24, 2024	OtherD (derivative)	-46,000	0.00 USD	—	SEC
Orchard Therapeutics plcListing unverified	Jan 24, 2024	Other	-44,391	—	—	SEC
Orchard Therapeutics plcListing unverified	Jan 24, 2024	OtherD (derivative)	-105,000	0.00 USD	—	SEC
Fulcrum Therapeutics, Inc.Listing on record	Jun 29, 2023	AwardD (derivative)	30,000	0.00 USD	—	SEC
PALVELLA THERAPEUTICS, INC.Listing unverified	Jun 23, 2023	AwardD (derivative)	45,000	0.00 USD	—	SEC
Orchard Therapeutics plcListing unverified	Jun 16, 2023	AwardD (derivative)	105,000	0.00 USD	—	SEC
Voyager Therapeutics, Inc.Listing on record	Jun 7, 2023	AwardD (derivative)	22,000	0.00 USD	—	SEC
Fulcrum Therapeutics, Inc.Listing on record	Jun 29, 2022	AwardD (derivative)	19,000	0.00 USD	—	SEC
Aceragen, Inc.Listing unverified	Jun 27, 2022	AwardD (derivative)	26,000	0.00 USD	—	SEC
PALVELLA THERAPEUTICS, INC.Listing unverified	Jun 24, 2022	AwardD (derivative)	45,000	0.00 USD	—	SEC
Orchard Therapeutics plcListing unverified	Jun 8, 2022	AwardD (derivative)	46,000	0.00 USD	—	SEC
Voyager Therapeutics, Inc.Listing on record	Jun 8, 2022	AwardD (derivative)	22,000	0.00 USD	—	SEC
PALVELLA THERAPEUTICS, INC.Listing unverified	Jun 29, 2021	AwardD (derivative)	45,000	0.00 USD	—	SEC
Fulcrum Therapeutics, Inc.Listing on record	Jun 29, 2021	Buy	10,000	9.16 USD	$91.6K	SEC
Orchard Therapeutics plcListing unverified	Jun 17, 2021	AwardD (derivative)	40,000	0.00 USD	—	SEC
Fulcrum Therapeutics, Inc.Listing on record	Jun 11, 2021	AwardD (derivative)	15,000	0.00 USD	—	SEC
Aceragen, Inc.Listing unverified	Jun 10, 2021	AwardD (derivative)	26,000	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Fulcrum Therapeutics, Inc.Listing on record	Jul 2, 2026	AwardD (derivative)	32,000	0.00 USD	—	SEC
Voyager Therapeutics, Inc.Listing on record	Jun 11, 2026	AwardD (derivative)	30,000	0.00 USD	—	SEC
Fulcrum Therapeutics, Inc.Listing on record	Jun 30, 2025	AwardD (derivative)	36,000	0.00 USD	—	SEC
Voyager Therapeutics, Inc.Listing on record	Jun 4, 2025	AwardD (derivative)	24,000	0.00 USD	—	SEC
PALVELLA THERAPEUTICS, INC.Listing unverified	Dec 12, 2024	Other	-1	0.01 USD	$0	SEC
PALVELLA THERAPEUTICS, INC.Listing unverified	Oct 28, 2024	Buy	1	1.00 USD	$1	SEC
Fulcrum Therapeutics, Inc.Listing on record	Jun 18, 2024	AwardD (derivative)	30,000	0.00 USD	—	SEC
Voyager Therapeutics, Inc.Listing on record	Jun 7, 2024	AwardD (derivative)	24,000	0.00 USD	—	SEC
Orchard Therapeutics plcListing unverified	Jan 24, 2024	OtherD (derivative)	-46,000	0.00 USD	—	SEC
Orchard Therapeutics plcListing unverified	Jan 24, 2024	Other	-44,391	—	—	SEC
Orchard Therapeutics plcListing unverified	Jan 24, 2024	OtherD (derivative)	-105,000	0.00 USD	—	SEC
Fulcrum Therapeutics, Inc.Listing on record	Jun 29, 2023	AwardD (derivative)	30,000	0.00 USD	—	SEC
PALVELLA THERAPEUTICS, INC.Listing unverified	Jun 23, 2023	AwardD (derivative)	45,000	0.00 USD	—	SEC
Orchard Therapeutics plcListing unverified	Jun 16, 2023	AwardD (derivative)	105,000	0.00 USD	—	SEC
Voyager Therapeutics, Inc.Listing on record	Jun 7, 2023	AwardD (derivative)	22,000	0.00 USD	—	SEC
Fulcrum Therapeutics, Inc.Listing on record	Jun 29, 2022	AwardD (derivative)	19,000	0.00 USD	—	SEC
Aceragen, Inc.Listing unverified	Jun 27, 2022	AwardD (derivative)	26,000	0.00 USD	—	SEC
PALVELLA THERAPEUTICS, INC.Listing unverified	Jun 24, 2022	AwardD (derivative)	45,000	0.00 USD	—	SEC
Orchard Therapeutics plcListing unverified	Jun 8, 2022	AwardD (derivative)	46,000	0.00 USD	—	SEC
Voyager Therapeutics, Inc.Listing on record	Jun 8, 2022	AwardD (derivative)	22,000	0.00 USD	—	SEC
PALVELLA THERAPEUTICS, INC.Listing unverified	Jun 29, 2021	AwardD (derivative)	45,000	0.00 USD	—	SEC
Fulcrum Therapeutics, Inc.Listing on record	Jun 29, 2021	Buy	10,000	9.16 USD	$91.6K	SEC
Orchard Therapeutics plcListing unverified	Jun 17, 2021	AwardD (derivative)	40,000	0.00 USD	—	SEC
Fulcrum Therapeutics, Inc.Listing on record	Jun 11, 2021	AwardD (derivative)	15,000	0.00 USD	—	SEC
Aceragen, Inc.Listing unverified	Jun 10, 2021	AwardD (derivative)	26,000	0.00 USD	—	SEC